Physician profile
David K Chow
NPI 1134262892
$2,592.54
in general payments reported to CMS, 2019-2025
11 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2021: $149 · 2022: $613 · 2023: $1,016 · 2024: $222 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $859.63 | 2019-2023 | Argos, Clareon, Constellation |
| Abbvie INC. | $697.79 | 2022-2023 | Vuity, Durysta, Xen Glaucoma Treatment System |
| Apellis Pharmaceuticals, INC. | $190.95 | 2023 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $171.14 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $163.30 | 2019-2025 | |
| Dompe US, INC. | $158.20 | 2023-2025 | Oxervate |
| Coopervision INC. | $143.27 | 2024 | Misight Contact Lens |
| Kala Pharmaceuticals, INC. | $124.80 | 2019 | |
| Oyster Point Pharma, INC. | $45.70 | 2022-2024 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $20.13 | 2023 | Acthar |
| Bausch & Lomb Americas INC. | $17.63 | 2024 | Xiidra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.